Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

17.1%

95 terminated/withdrawn out of 554 trials

Success Rate

71.6%

-14.9% vs industry average

Late-Stage Pipeline

11%

60 trials in Phase 3/4

Results Transparency

52%

124 of 239 completed trials have results

Key Signals

89 recruiting124 with results57 terminated38 withdrawn

Enrollment Performance

Analytics

N/A

236(57.6%)

Phase 2

60(14.6%)

Phase 4

45(11.0%)

Phase 1

39(9.5%)

Early Phase 1

15(3.7%)

Phase 3

15(3.7%)

410Total

N/A(236)

Phase 2(60)

Phase 4(45)

Phase 1(39)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (554)

Showing 20 of 554 trials

NCT05868369Not ApplicableActive Not Recruiting

The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy

Role: lead

NCT05692323Not ApplicableActive Not Recruiting

A Supervised Prehabilitation Program for Patients With Pancreatic Cancer

Role: lead

NCT07524218Not ApplicableNot Yet Recruiting

Effect of Meal Timing During Adjuvant Treatment for Cancer

Role: collaborator

NCT03707431Not ApplicableCompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Role: collaborator

NCT05552053Phase 2Active Not Recruiting

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

Role: lead

NCT06133075Phase 2Completed

Using Mirabegron to Increase BP in Patients With POTS

Role: lead

NCT07017673Phase 2Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Role: lead

NCT04071951Not ApplicableActive Not Recruiting

Pharmacist Intervention to Reduce Post-Hospitalization Utilization

Role: lead

NCT04124120Not ApplicableRecruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Role: collaborator

NCT07495995Phase 2Not Yet Recruiting

SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis

Role: lead

NCT04250259Phase 2Recruiting

SAMe Trial for Patients With Alcoholic Cirrhosis

Role: collaborator

NCT05701657Not ApplicableRecruiting

Nutrition for Precision Health, Powered by the All of Us

Role: collaborator

NCT07499089Not Yet Recruiting

Together-Breast Cancer Support Platform

Role: lead

NCT04933474Not ApplicableCompleted

Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain

Role: lead

NCT05837286Not ApplicableRecruiting

Conservative Treatment of Trigger Finger

Role: lead

NCT00921609Completed

Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly

Role: lead

NCT06110156Not ApplicableActive Not Recruiting

Population Health Approach to Optimizing Medications in Older Adults

Role: lead

NCT06016257Not ApplicableRecruiting

Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study

Role: lead

NCT02422498Phase 2Active Not Recruiting

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

Role: collaborator

NCT05838547Recruiting

CANF-Comb-II PET-MR in Atherosclerosis Multisite

Role: collaborator